Siegel S E, Nesbit M E, Baehner R, Sather H, Hammond G D
Am J Dis Child. 1980 Jan;134(1):28-34. doi: 10.1001/archpedi.1980.02130130020007.
The incidence of pneumonia was evaluated in 844 children undergoing initial treatment for acute lymphoblastic leukemia (ALL). A total of 310 episodes occurred in 239 patients followed up for five to 36 months after diagnosis. The peak incidences occurred in the periods 0 to 20 days and 40 to 80 days after the start of antileukemic therapy. Bacterial pneumonias occurred primarily during the first 20 days after diagnosis of ALL. No episode of Pneumocystis carinii pneumonia was noted before 40 days, and the majority of instances occurred 50 to 120 days after diagnosis. In 80% of all episodes, a specific causative organism was not detected. The incidence of P carinii pneumonia was greater in patients receiving intrathecal methotrexate as part of CNS prophylaxis than in those receiving only CNS irradiation. Pneumonia is a frequent event during the therapy of ALL in childhood.
对844名接受急性淋巴细胞白血病(ALL)初始治疗的儿童的肺炎发病率进行了评估。在诊断后随访5至36个月的239名患者中,共发生了310次发作。发病高峰出现在抗白血病治疗开始后的0至20天和40至80天。细菌性肺炎主要发生在ALL诊断后的前20天内。在40天之前未发现卡氏肺孢子虫肺炎病例,大多数病例发生在诊断后的50至120天。在所有发作中,80%未检测到特定的致病生物体。作为中枢神经系统预防措施一部分接受鞘内甲氨蝶呤治疗的患者,卡氏肺孢子虫肺炎的发病率高于仅接受中枢神经系统照射的患者。肺炎是儿童ALL治疗期间的常见事件。